Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
18,06 GBX | -1,07% | +1,72% | -74,21% |
25/04 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 | |
25/04 | AIM WINNAARS EN VERLIEZERS: Kromek springt 14% op Amerikaans overheidscontract | AN |
Vakgebied
Aantal werknemers: 24
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 59 | 01-09-23 | |
William Love
FOU | Founder | 62 | 04-03-96 |
Shaun Claydon
DFI | Director of Finance/CFO | 56 | 24-10-18 |
Jim Lees
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Chief Tech/Sci/R&D Officer | - | 01-01-98 | |
Yuri Martina
CTO | Chief Tech/Sci/R&D Officer | - | 03-05-22 |
Director/Board Member | 61 | 01-01-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anthony Rudd
CHM | Chairman | 76 | 01-09-11 |
William Love
FOU | Founder | 62 | 04-03-96 |
Nigel Brooksby
BRD | Director/Board Member | - | 01-06-22 |
Shaun Claydon
DFI | Director of Finance/CFO | 56 | 24-10-18 |
Director/Board Member | 61 | 01-01-20 | |
James Stearns
BRD | Director/Board Member | - | 01-06-22 |
Aled Williams
BRD | Director/Board Member | - | 01-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 95 311 863 | 71 818 619 ( 75,35 %) | 0 | 75,35 % |
Bedrijfsgegevens
Destiny Pharma Plc
Sussex Innovation Centre Science Park Square
BN1 9SB, Brighton
+44 1273 704440
http://www.destinypharma.comSector
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-74,21% | 21,87 mln. | |
+9,63% | 106 mld. | |
+0,03% | 104 mld. | |
+6,70% | 23,25 mld. | |
-13,78% | 22,5 mld. | |
-6,68% | 18,7 mld. | |
-37,08% | 17,95 mld. | |
-10,68% | 16,99 mld. | |
+7,45% | 14,26 mld. | |
+38,53% | 12,76 mld. |
- Beurs
- Aandelen
- Koers DEST
- Onderneming Destiny Pharma plc